Research and Development

Our Research and Development (R&D) efforts are dedicated to creating new and innovative pharmaceuticals for the treatment of psychiatric and neurological disorders. Through investment and perseverance, we strive to create the very best treatments for patients.

We are the only fully-integrated pharmaceutical company in the world, solely devoted to the treatment of psychiatric and neurological disorders. We dedicate our entire R&D efforts to develop innovative drugs for treatment of a number of psychiatric and neurological disorders. Our R&D projects focus on: Alzheimer’s disease, Depression, Parkinson’s disease, and Schizophrenia.

Show More Options

Save Category as RSS Feed

Results 1 – 7 of 7 Page 1 of 1

Search results for "". Page 1 of 1, Results 1 to 7
Title	Location	Country
Title	Location	Country	Reset

Graduate CMC Biologics Graduate CMC Biologics Copenhagen, Hovedstaden, DK 11-Jan-2021 0.00 km	Copenhagen, Hovedstaden, DK	Denmark
Directeur(trice) principal(e), Affaires médicales et réglementaires Directeur(trice) principal(e), Affaires médicales et réglementaires Montreal, Quebec, CA 30-Dec-2020 0.00 km	Montreal, Quebec, CA	Canada
Senior Director, Medical and Regulatory Affairs Senior Director, Medical and Regulatory Affairs Montreal, Quebec, CA 30-Dec-2020 0.00 km	Montreal, Quebec, CA	Canada
Senior Director Drug Product and Formulation Development Senior Director Drug Product and Formulation Development Bothell, Washington, US 30-Dec-2020 0.00 km	Bothell, Washington, US	United States
Associate Director, Clinical Lead Neuropsychiatry - Remote Opportunity Associate Director, Clinical Lead Neuropsychiatry - Remote Opportunity Boston, Massachusetts, US 29-Dec-2020 0.00 km	Boston, Massachusetts, US	United States
Senior Scientist, Formulations Senior Scientist, Formulations Bothell, Washington, US 29-Dec-2020 0.00 km	Bothell, Washington, US	United States
Proteomics Scientist Proteomics Scientist San Diego, California, US 27-Dec-2020 0.00 km	San Diego, California, US	United States